Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 28.38M P/E - EPS this Y 14.30% Ern Qtrly Grth -
Income -40.69M Forward P/E -0.79 EPS next Y -4.60% 50D Avg Chg -7.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -18.00%
Dividend N/A Price/Book 0.30 EPS next 5Y - 52W High Chg -45.00%
Recommedations 1.40 Quick Ratio 15.86 Shares Outstanding 20.63M 52W Low Chg 14.00%
Insider Own 6.13% ROA -28.11% Shares Float 15.17M Beta 1.85
Inst Own 51.36% ROE -45.91% Shares Shorted/Prior 2.10M/1.88M Price 2.51
Gross Margin - Profit Margin - Avg. Volume 34,432 Target Price 26.40
Oper. Margin - Earnings Date Nov 1 Volume 42,949 Change -1.18%
About Protara Therapeutics, Inc.

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy that is in Phase II clinical trial for patients receiving parenteral nutrition. The company is headquartered in New York, New York.

Protara Therapeutics, Inc. News
11/15/24 Protara Therapeutics to Present New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the 25th Annual Meeting of the Society of Urologic Oncology
11/12/24 Protara Therapeutics Announces Third Quarter 2024 Financial Results and Provides a Business Update
11/06/24 Protara Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference
10/21/24 Protara Therapeutics Granted FDA Fast Track Designation for Intravenous Choline Chloride for Patients Receiving Parenteral Support
09/09/24 Protara Therapeutics Announces Completion of First Cohort in Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations
09/09/24 Protara Therapeutics Announces Results from THRIVE-1, a Prospective Observational Study Evaluating the Prevalence of Choline Deficiency and Liver Injury in Patients Dependent on Parenteral Support
09/03/24 Protara Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
08/08/24 Will Protara Therapeutics (NASDAQ:TARA) Spend Its Cash Wisely?
08/06/24 Protara Therapeutics Announces Second Quarter 2024 Financial Results and Provides a Business Update
04:06 PM Protara Therapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05/21/24 Protara Therapeutics to Present at the TD Cowen 5th Annual Oncology Innovation Summit
05/02/24 Protara Therapeutics Announces First Quarter 2024 Financial Results and Provides Business Update
04/05/24 Protara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing
04/05/24 Protara Therapeutics Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition
04/05/24 Protara Therapeutics Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC
03/13/24 Protara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
02/28/24 Protara Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
02/17/24 We're Keeping An Eye On Protara Therapeutics' (NASDAQ:TARA) Cash Burn Rate
01/31/24 Protara Therapeutics to Participate in Upcoming Investor Conferences
11/30/23 Protara Therapeutics Announces Presentation of Additional Encouraging Data from Phase 1a ADVANCED-1 Trial of TARA-002 in NMIBC at the 24th Annual Meeting of the Society of Urologic Oncology
TARA Chatroom

User Image lovestockstwits Posted - 4 days ago

$TARA I guess pumpers left

User Image lovestockstwits Posted - 4 days ago

$TARA everyday down

User Image ESanta Posted - 1 week ago

$TARA

User Image GreedyD Posted - 1 week ago

$TARA 15% of the float short. Burn these bitches

User Image vmsrena Posted - 1 week ago

$TARA Enough cash to fund threw 2026 great news. Great news in earnings report.

User Image Almora34 Posted - 2 weeks ago

$TARA Out with %35 profit. If I see around 2.5 I may enter again. Good luck to who holds3 it.

User Image Wall_e_J Posted - 2 weeks ago

$TARA

User Image Wall_e_J Posted - 2 weeks ago

$SRM $CYN $TARA $ZYXI

User Image SqueezeFinder1 Posted - 3 weeks ago

Here are some tickers with nice charts and/or upcoming scheduled events to keep on your radar going forward, and their respective confidence levels ranging from 1-3 🍊. (Please note that confidence levels are subjective to personal observation and strategy, and should be reviewed individually prior to assuming success potential) 4. $TARA Squeezability Score: 55% Juice Target: 4.9 Confidence: 🍊 🍊 Price: 2.51 (+7.3%) Breakdown point: 2.2 Breakout point: 3.0 Mentions (30D): 1 Event/Condition: Slightly elevated weekly rel vol + Short-term bullish momentum + Potential medium-term downtrend bullish reversal. 5. $EYPT Squeezability Score: 53% Juice Target: 17.3 Confidence: 🍊 🍊 Price: 11.76 (+2.6%) Breakdown point: 10.35 Breakout point: 14.00 Mentions (30D): 5 Event/Condition: Rel vol ramp + Closed $140M registered up sized offering @ $11/share + Short-term bullish momentum following positive trial results for diabetic macular edema drug. Check my profile for more ideas and daily ALERTS :)

User Image PenkeTrading Posted - 3 weeks ago

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Protara Therapeutics Inc. Is that bullish or bearish? $TARA #Protara #RsiOverbought #NASDAQ

User Image Cdmb1177 Posted - 3 weeks ago

$TARA If you like Tara. Check out CRDF it’s got great potential

User Image jacksparo Posted - 10/31/24

$TARA Almost 35% gain from my email alert regardless the red market βœ…πŸ“ˆβœ…

User Image Pmills1111 Posted - 10/31/24

$TARA patience is key

User Image DougieFreshPicks Posted - 10/31/24

$TARA she is moving this morning!!!

User Image Lovethespace27 Posted - 10/30/24

$TARA

User Image jacksparo Posted - 10/28/24

$TARA Another successful one πŸ“ˆπŸ“ˆ! From my email πŸ“ˆβœ…! Closed at 2.40 βœ…

User Image Shqipe1 Posted - 10/28/24

$TARA πŸ‘€

User Image DougieFreshPicks Posted - 10/28/24

$TARA there we go!!!

User Image Bulltrader988 Posted - 10/28/24

$TARA lets go

User Image justiceforb_85 Posted - 10/25/24

$TARA wondering why the stock has been trading so low for past six months if preliminary data for TARA-002 in lymphatic malformations was positive? It appears more data will be released in early 2025..

User Image Cdmb1177 Posted - 10/25/24

$TARA get onboard next stop 3+ then πŸš€πŸš€πŸš€πŸš€πŸš€ time.

User Image Stocksrunner Posted - 10/25/24

πŸ“ˆ What a comeback! These stocks started down but finished strong today: $NWTN $LTBR $ALLK $STTK $TARA πŸ’₯ Impressive reversals that show serious resilienceβ€”keep an eye on these bounce-back champs!

User Image stockdude550 Posted - 10/25/24

$TARA I guess it bottomed? 🀣

User Image jacksparo Posted - 10/25/24

$TARA My VIP team weekly email βœ…πŸ“ˆ! We made one of the easiest trade. No stress No wasted time while your finger on the push button! Simple plan with entry exit SL. That’s all βœ…πŸ“ˆ!

User Image DougieFreshPicks Posted - 10/25/24

$TARA she did her makeup and is looking good πŸ€·πŸ»β€β™‚οΈπŸ€£

User Image Bulltrader988 Posted - 10/25/24

$TARA πŸ‘€πŸ‘€πŸ‘€πŸ‘€ lets go

User Image dindinn Posted - 4 weeks ago

$TARA $COCP listen to mark @momo2021

User Image Beanie_Mojo Posted - 4 weeks ago

$TARA

User Image Bulltrader988 Posted - 4 weeks ago

$TARA $MNPR

User Image Bulltrader988 Posted - 4 weeks ago

$TARA something cooking?πŸ‘€πŸ‘€

Analyst Ratings
Oppenheimer Outperform Aug 12, 24
HC Wainwright & Co. Buy Aug 8, 24
HC Wainwright & Co. Buy May 6, 24
Oppenheimer Outperform Apr 22, 24
HC Wainwright & Co. Buy Apr 8, 24
HC Wainwright & Co. Buy Mar 14, 24
HC Wainwright & Co. Buy Aug 4, 23
HC Wainwright & Co. Buy May 8, 23
HC Wainwright & Co. Buy May 1, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Opaleye Management Inc. 10% Owner 10% Owner Dec 30 Sell 2.71 15,473 41,932 130,000 12/30/22
Opaleye Management Inc. 10% Owner 10% Owner Sep 14 Buy 3.89 23,900 92,971 132,300 09/15/22
Shefferman Jesse CEO and President CEO and President Aug 11 Buy 3.84 9,065 34,810 879,441 08/15/22
Opaleye Management Inc. 10% Owner 10% Owner Apr 07 Buy 4.77 10,136 48,349 127,500 04/15/22
BESHAR LUKE M Director Director Mar 14 Buy 4.25 10,000 42,500 188,000 03/16/22
BESHAR LUKE M Director Director Mar 10 Buy 4.4555 10,000 44,555 178,000 03/14/22
Opaleye Management Inc. 10% Owner 10% Owner Dec 28 Buy 6.57 11,591 76,153 120,000 12/29/21
Opaleye Management Inc. 10% Owner 10% Owner Dec 23 Buy 6.57 38,000 249,660 110,000 12/27/21
Marshall Randall - - Sep 15 Sell 19.63 2,554 50,135 585,600 09/15/20